Search research articles
Contact Us
Filters
Showing results (111-120 of 150) with videos related to
Page
of 15
Sort By:
European Journal of Medicinal Chemistry
|
October 15, 2017
Crassiflorone derivatives that inhibit Trypanosoma brucei glyceraldehyde-3-phosphate dehydrogenase (TbGAPDH) and Trypanosoma cruzi trypanothione reductase (TcTR) and display trypanocidal activity
Elisa Uliassi, Giulia Fiorani, R Luise Krauth-Siegel, et al.
Molecules (Basel, Switzerland)
|
July 24, 2021
Design, Synthesis and Antiparasitic Evaluation of Click Phospholipids
George E Magoulas, Pantelis Afroudakis, Kalliopi Georgikopoulou, et al.
Molecules (Basel, Switzerland)
|
March 12, 2017
Chroman-4-One Derivatives Targeting Pteridine Reductase 1 and Showing Anti-Parasitic Activity
Flavio Di Pisa, Giacomo Landi, Lucia Dello Iacono, et al.
The Journal of Antimicrobial Chemotherapy
|
May 5, 2026
A strategic discovery roadmap towards high-quality leads and drug development candidates for kinetoplastid diseases. Part 1: setting the stage
Sarah Hendrickx, Kayhan Ilbeigi, Eli S J Thoré, et al.
Cell Chemical Biology
|
July 30, 2019
Activation of Caspase-6 Is Promoted by a Mutant Huntingtin Fragment and Blocked by an Allosteric Inhibitor Compound
Dagmar E Ehrnhoefer, Niels H Skotte, Jeanette Reinshagen, et al.
Journal of Medicinal Chemistry
|
November 3, 2023
High-Throughput Phenotypic Screening and Machine Learning Methods Enabled the Selection of Broad-Spectrum Low-Toxicity Antitrypanosomatidic Agents
Pasquale Linciano, Antonio Quotadamo, Rosaria Luciani, et al.
The Journal of Antimicrobial Chemotherapy
|
March 31, 2026
A strategic discovery roadmap towards high-quality leads and drug development candidates for kinetoplastid diseases. Part 2: from molecule to confirmed hit
Sarah Hendrickx, Kayhan Ilbeigi, Eli S J Thoré, et al.
Circulation Research
|
September 7, 2023
ADAMTS-7 Modulates Atherosclerotic Plaque Formation by Degradation of TIMP-1
M Amin Sharifi, Michael Wierer, Tan An Dang, et al.
The Journal of Antimicrobial Chemotherapy
|
May 11, 2026
A strategic discovery roadmap towards high-quality leads and drug development candidates for kinetoplastid diseases. Part 3: from lead towards a drug development candidate
Sarah Hendrickx, Kayhan Ilbeigi, Eli S J Thoré, et al.
Biomedical Reports
|
March 23, 2018
Therapeutics discovery: From bench to first in-human trials
Ensaf M Al-Hujaily, Tanvir Khatlani, Zeyad Alehaideb, et al.
Page
of 15
Search research articles
Search
Showing results (111-120 of 150) with videos related to
Sort By:
Page
of 15
European Journal of Medicinal Chemistry
|
October 15, 2017
Crassiflorone derivatives that inhibit Trypanosoma brucei glyceraldehyde-3-phosphate dehydrogenase (TbGAPDH) and Trypanosoma cruzi trypanothione reductase (TcTR) and display trypanocidal activity
Elisa Uliassi, Giulia Fiorani, R Luise Krauth-Siegel, et al.
Molecules (Basel, Switzerland)
|
July 24, 2021
Design, Synthesis and Antiparasitic Evaluation of Click Phospholipids
George E Magoulas, Pantelis Afroudakis, Kalliopi Georgikopoulou, et al.
Molecules (Basel, Switzerland)
|
March 12, 2017
Chroman-4-One Derivatives Targeting Pteridine Reductase 1 and Showing Anti-Parasitic Activity
Flavio Di Pisa, Giacomo Landi, Lucia Dello Iacono, et al.
The Journal of Antimicrobial Chemotherapy
|
May 5, 2026
A strategic discovery roadmap towards high-quality leads and drug development candidates for kinetoplastid diseases. Part 1: setting the stage
Sarah Hendrickx, Kayhan Ilbeigi, Eli S J Thoré, et al.
Cell Chemical Biology
|
July 30, 2019
Activation of Caspase-6 Is Promoted by a Mutant Huntingtin Fragment and Blocked by an Allosteric Inhibitor Compound
Dagmar E Ehrnhoefer, Niels H Skotte, Jeanette Reinshagen, et al.
Journal of Medicinal Chemistry
|
November 3, 2023
High-Throughput Phenotypic Screening and Machine Learning Methods Enabled the Selection of Broad-Spectrum Low-Toxicity Antitrypanosomatidic Agents
Pasquale Linciano, Antonio Quotadamo, Rosaria Luciani, et al.
The Journal of Antimicrobial Chemotherapy
|
March 31, 2026
A strategic discovery roadmap towards high-quality leads and drug development candidates for kinetoplastid diseases. Part 2: from molecule to confirmed hit
Sarah Hendrickx, Kayhan Ilbeigi, Eli S J Thoré, et al.
Circulation Research
|
September 7, 2023
ADAMTS-7 Modulates Atherosclerotic Plaque Formation by Degradation of TIMP-1
M Amin Sharifi, Michael Wierer, Tan An Dang, et al.
The Journal of Antimicrobial Chemotherapy
|
May 11, 2026
A strategic discovery roadmap towards high-quality leads and drug development candidates for kinetoplastid diseases. Part 3: from lead towards a drug development candidate
Sarah Hendrickx, Kayhan Ilbeigi, Eli S J Thoré, et al.
Biomedical Reports
|
March 23, 2018
Therapeutics discovery: From bench to first in-human trials
Ensaf M Al-Hujaily, Tanvir Khatlani, Zeyad Alehaideb, et al.
Page
of 15